JP2021525083A5 - - Google Patents
Info
- Publication number
- JP2021525083A5 JP2021525083A5 JP2020565415A JP2020565415A JP2021525083A5 JP 2021525083 A5 JP2021525083 A5 JP 2021525083A5 JP 2020565415 A JP2020565415 A JP 2020565415A JP 2020565415 A JP2020565415 A JP 2020565415A JP 2021525083 A5 JP2021525083 A5 JP 2021525083A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sodium phosphate
- methionine
- sucrose
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024039768A JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862676525P | 2018-05-25 | 2018-05-25 | |
| US62/676,525 | 2018-05-25 | ||
| PCT/US2019/033983 WO2019227029A1 (en) | 2018-05-25 | 2019-05-24 | Pharmaceutical compositions for treating acid sphingomyelinase deficiency |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024039768A Division JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525083A JP2021525083A (ja) | 2021-09-24 |
| JP2021525083A5 true JP2021525083A5 (https=) | 2022-05-26 |
| JP7497300B2 JP7497300B2 (ja) | 2024-06-10 |
Family
ID=66912954
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565415A Active JP7497300B2 (ja) | 2018-05-25 | 2019-05-24 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
| JP2024039768A Active JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024039768A Active JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210145941A1 (https=) |
| EP (1) | EP3802805A1 (https=) |
| JP (2) | JP7497300B2 (https=) |
| KR (1) | KR102852946B1 (https=) |
| CN (1) | CN112424347A (https=) |
| AU (2) | AU2019275109C1 (https=) |
| BR (1) | BR112020023829A2 (https=) |
| CA (1) | CA3101688A1 (https=) |
| CO (1) | CO2020014399A2 (https=) |
| IL (1) | IL278964A (https=) |
| MX (2) | MX2020012700A (https=) |
| PY (1) | PY1939780A (https=) |
| SG (1) | SG11202011488WA (https=) |
| UY (1) | UY38238A (https=) |
| WO (1) | WO2019227029A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4284442A4 (en) * | 2021-02-01 | 2025-04-23 | The Trustees of The University of Pennsylvania | COMPOSITIONS AND METHODS FOR TREATING NIEMANN PICK DISEASE TYPE A |
| TW202403043A (zh) | 2022-03-18 | 2024-01-16 | 美商健臻公司 | 重組人類酸性鞘磷脂酶醫藥組合物及方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5773278A (en) | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
| EP1450847B1 (en) | 2001-11-13 | 2010-09-29 | Genentech, Inc. | APO2 ligand/ TRAIL formulations and uses thereof |
| EP1638595B1 (en) | 2003-06-20 | 2013-03-20 | Ares Trading S.A. | Freeze-dried fsh / lh formulations |
| CN101214249A (zh) * | 2003-11-25 | 2008-07-09 | 纽约大学西奈山医学院 | 尼曼-皮克病的基于陪伴分子的治疗 |
| AR059089A1 (es) * | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
| HRP20120994T1 (hr) | 2006-02-07 | 2012-12-31 | Shire Human Genetic Therapies, Inc. | Stabilizirana smjesa glukocerebrozidaze |
| AU2007226582B2 (en) * | 2006-03-13 | 2012-07-05 | Revvity Health Sciences, Inc. | Substrates and internal standards for mass spectroscopy detection |
| JP2009530284A (ja) * | 2006-03-13 | 2009-08-27 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | 拡張期心不全を治療するための方法と組成物 |
| JP2012530721A (ja) | 2009-06-18 | 2012-12-06 | ワイス・エルエルシー | 小モジュール免疫薬のための凍結乾燥製剤 |
| SI3998078T1 (sl) | 2009-08-28 | 2026-02-27 | Genzyme Corporation | Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze |
| JP6073783B2 (ja) * | 2010-06-25 | 2017-02-01 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | ヘパランｎ−スルファターゼのｃｎｓ送達のための方法および組成物 |
| PL3241547T3 (pl) | 2011-03-31 | 2021-02-08 | Medy-Tox Inc. | Liofilizowany preparat toksyny botulinowej |
| JP6480154B2 (ja) | 2014-11-06 | 2019-03-06 | 持田製薬株式会社 | エタネルセプトの凍結乾燥製剤 |
| FI126979B (en) * | 2016-02-29 | 2017-09-15 | Faron Pharmaceuticals Oy | Lyophilized pharmaceutical formulation and its use |
| KR20250025051A (ko) * | 2017-08-24 | 2025-02-20 | 사노피 | 산성 스핑고미엘린분해효소 결핍증 환자에서의 비정상적 골병태의 치료 |
-
2019
- 2019-05-23 PY PY201901939780A patent/PY1939780A/es unknown
- 2019-05-23 UY UY0001038238A patent/UY38238A/es not_active Application Discontinuation
- 2019-05-24 CN CN201980048133.7A patent/CN112424347A/zh active Pending
- 2019-05-24 AU AU2019275109A patent/AU2019275109C1/en active Active
- 2019-05-24 SG SG11202011488WA patent/SG11202011488WA/en unknown
- 2019-05-24 EP EP19731419.8A patent/EP3802805A1/en active Pending
- 2019-05-24 WO PCT/US2019/033983 patent/WO2019227029A1/en not_active Ceased
- 2019-05-24 MX MX2020012700A patent/MX2020012700A/es unknown
- 2019-05-24 JP JP2020565415A patent/JP7497300B2/ja active Active
- 2019-05-24 CA CA3101688A patent/CA3101688A1/en active Pending
- 2019-05-24 KR KR1020207037328A patent/KR102852946B1/ko active Active
- 2019-05-24 BR BR112020023829-5A patent/BR112020023829A2/pt unknown
-
2020
- 2020-11-20 CO CONC2020/0014399A patent/CO2020014399A2/es unknown
- 2020-11-25 MX MX2025002733A patent/MX2025002733A/es unknown
- 2020-11-25 IL IL278964A patent/IL278964A/en unknown
- 2020-11-25 US US17/104,593 patent/US20210145941A1/en active Pending
-
2024
- 2024-03-14 JP JP2024039768A patent/JP7832245B2/ja active Active
-
2025
- 2025-07-17 AU AU2025205577A patent/AU2025205577A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012523414A5 (https=) | ||
| FI4243825T3 (fi) | Omekamtiivimekarbiili sydämen vajaatoiminnan hoitoon valikoiduilla potilasryhmillä | |
| CN102643339B (zh) | 一种glp-1类似物、制备方法及其应用 | |
| JP2024069459A5 (https=) | ||
| DE60031405D1 (de) | Bereitstellung von peptiden mit kleeblattstruktur | |
| JP2019533722A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2021525083A5 (https=) | ||
| JP2010501596A5 (https=) | ||
| US20090182055A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| JP2015527125A5 (https=) | ||
| JP2005506275A5 (https=) | ||
| CN105903003A (zh) | 一种改善废用性骨质疏松的组合物及其应用 | |
| JP2020509052A5 (https=) | ||
| CN1160123C (zh) | 乌司他丁用于治疗严重急性呼吸综合征的用途及其药物组合物 | |
| RU2024125372A (ru) | Фармацевтические композиции для лечения недостаточности кислой сфингомиелиназы | |
| JP4630931B2 (ja) | 消化管溶性剤型 | |
| WO2017181978A1 (zh) | 贻贝粘蛋白产品及其抑制血管炎症的应用 | |
| CN118831041A (zh) | 一种纳米酶凝胶及其制备方法和应用 | |
| EP4477223A4 (en) | A pharmaceutical composition comprising allopurinol, febuxostat, or a pharmaceutically acceptable salt, combined for the prevention or treatment of chronic nephropathy in a patient with elevated blood uric acid levels. | |
| JP2014512369A5 (https=) | ||
| CN103923208B (zh) | 一种重组人角质细胞生长因子-2突变体的活性稳定剂 | |
| CN104208189A (zh) | 治疗复发性口腔溃疡的中药制剂 | |
| AU2002229678B2 (en) | Ribavirin granulate for producing coated tablets | |
| Park et al. | Esophageal achalasia compressing left atrium diagnosed by echocardiography using a liquid containing carbon dioxide in a 21-year-old woman with Turner syndrome |